|
Re: Question on valuing shares from time of spinoff
|
6
|
Zenith Epigenetics
|
Jul 18, 2018 04:13PM
|
|
Re: Questions for Q1 webcast
|
3
|
Resverlogix Corp.
|
Mar 20, 2016 11:56AM
|
|
Re: Questions for Q1 webcast
|
4
|
Resverlogix Corp.
|
Mar 05, 2016 12:45PM
|
|
Re: Ray Kroc
|
1
|
Resverlogix Corp.
|
Aug 22, 2020 07:25PM
|
|
Re: Ray Kroc
|
1
|
Resverlogix Corp.
|
Aug 22, 2020 07:29PM
|
|
Re: Ray Kroc
|
1
|
Resverlogix Corp.
|
Aug 22, 2020 08:48PM
|
|
Re: Ray Kroc
|
2
|
Resverlogix Corp.
|
Aug 23, 2020 01:44PM
|
|
Re: Ray Kroc
|
1
|
Resverlogix Corp.
|
Aug 24, 2020 12:21AM
|
|
Re: Ray Kroc
|
1
|
Resverlogix Corp.
|
Aug 24, 2020 01:11PM
|
|
Re: Re San fran
|
8
|
Resverlogix Corp.
|
Oct 19, 2020 03:41PM
|
|
Re: Re San fran
|
1
|
Resverlogix Corp.
|
Oct 19, 2020 05:43PM
|
|
Re: Rebuys start at $2.28
|
6
|
Resverlogix Corp.
|
Aug 09, 2018 09:16PM
|
|
Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
|
7
|
Resverlogix Corp.
|
Jan 08, 2018 05:02PM
|
|
Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
|
5
|
Resverlogix Corp.
|
Jan 08, 2018 06:03PM
|
|
Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
|
6
|
Resverlogix Corp.
|
Jan 10, 2018 12:43AM
|
|
Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
|
6
|
Resverlogix Corp.
|
Jan 10, 2018 12:54AM
|
|
Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement
|
4
|
Resverlogix Corp.
|
Sep 05, 2017 05:48PM
|
|
Re: Resverlogix Expands Phase 2b Clinical Trial for COVID-19
|
11
|
Resverlogix Corp.
|
Feb 17, 2022 09:55AM
|
|
Re: Resverlogix Expands Phase 2b Clinical Trial for COVID-19
|
3
|
Resverlogix Corp.
|
Feb 17, 2022 12:24PM
|
|
Re: Resverlogix has been shortlisted for the Buzz of Bio award "Pipelines of Promise...
|
3
|
Resverlogix Corp.
|
Apr 04, 2017 09:23AM
|
